The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term

Abstract excerpt

PET (pre-eclamptic toxaemia) has recently been linked with alterations in production of a VEGFR1 [VEGF (vascular endothelial growth factor) receptor 1] splice variant that acts as a circulating inhibitor. We have recently described a family of naturally occurring splice variants of VEGF, termed VEGFxxxb, that also appear to act as inhibitors of conventional VEGFxxx-mediated angiogenesis. To determine whether...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers in Disease Mechanisms
• Share to Pregnancy and preeclampsia studies
• Share to Reproductive System and Pregnancy